149 related articles for article (PubMed ID: 7873913)
1. [Safety from HIV infection of preserved blood from Germany].
Gürtler L; München
Infusionsther Transfusionsmed; 1994 Dec; 21(6):360-1. PubMed ID: 7873913
[No Abstract] [Full Text] [Related]
2. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
Zeiler T; Kretschmer V; Sibrowski W
Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
[TBL] [Abstract][Full Text] [Related]
3. [HIV retrospective study of the German Red Cross blood donation service in Germany].
Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
[TBL] [Abstract][Full Text] [Related]
4. [HIV study of German Red Cross blood banks in Germany and Berlin].
Glück D; Kubanek B; Gaus W; Elbert G; Grässmann W; Hesse R; Holzberger G; Koerner K; Mendner T; Peichl-Hoffmann G
Beitr Infusionsther; 1991; 28():7-8. PubMed ID: 1725663
[TBL] [Abstract][Full Text] [Related]
5. A bloody mess. New safeguards will cut supplies of a lifesaving resource.
Sobel RK
US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392
[No Abstract] [Full Text] [Related]
6. Red Cross called to task for its handling of blood products.
IAPAC Mon; 2001 Feb; 7(2):40-1. PubMed ID: 11302024
[No Abstract] [Full Text] [Related]
7. Reduced risk of transfusion-transmitted HIV in Kenya through centrally co-ordinated blood centres, stringent donor selection and effective p24 antigen-HIV antibody screening.
Basavaraju SV; Mwangi J; Nyamongo J; Zeh C; Kimani D; Shiraishi RW; Madoda R; Okonji JA; Sugut W; Ongwae S; Pitman JP; Marum LH
Vox Sang; 2010 Oct; 99(3):212-9. PubMed ID: 20497410
[TBL] [Abstract][Full Text] [Related]
8. One year follow-up of a HIV seropositive jail population.
Scano G; Luzi G; Mezzaroma I; Aiuti F; Vellucci A; Guastini L; Lepri F; Starnini G
Allergol Immunopathol (Madr); 1991; 19(4):165-6. PubMed ID: 1818517
[TBL] [Abstract][Full Text] [Related]
9. [The safety of blood and blood products].
Löwer J
Internist (Berl); 1994 Oct; 35(10):929-33. PubMed ID: 8002228
[No Abstract] [Full Text] [Related]
10. Managing HIV. Part 8: controlling an epidemic. 8.4 Protecting the blood supply from HIV.
Wylie BR; Dodd RY
Med J Aust; 1996 Sep; 165(5):264-5. PubMed ID: 8816684
[TBL] [Abstract][Full Text] [Related]
11. [Needlestick injuries].
Kerwat K; Goedecke M; Wulf H
Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):344-5. PubMed ID: 19440942
[TBL] [Abstract][Full Text] [Related]
12. Risk of AIDS (HIV) transmission in 581 renal transplants.
Zaleski C; Burke G; Nery J; Roth D; Fernandez J; Babischkin S; Esquenazi V; Miller J
Transplant Proc; 1993 Feb; 25(1 Pt 2):1483-4. PubMed ID: 8442161
[No Abstract] [Full Text] [Related]
13. [Importance of introduction of PCR in blood banks].
Gürtler L
Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016
[No Abstract] [Full Text] [Related]
14. Blood safety and rational use of blood.
Chawla SC; Lal S
J Indian Med Assoc; 1994 Jan; 92(1):22-3. PubMed ID: 8207275
[TBL] [Abstract][Full Text] [Related]
15. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
[TBL] [Abstract][Full Text] [Related]
16. Prevention of blood-borne transmission of HIV.
Van de Perre P; Diakhate L; Watson-Williams J
AIDS; 1997; 11 Suppl B():S89-98. PubMed ID: 9416370
[No Abstract] [Full Text] [Related]
17. Keeping the U.S. blood supply safe.
MLO Med Lab Obs; 2010 Jul; 42(7):14, 16. PubMed ID: 20690450
[No Abstract] [Full Text] [Related]
18. Current good manufacturing practices for blood and blood components: notification of consignees receiving blood and blood components at increased risk for transmitting HIV infection--FDA. Final rule.
Fed Regist; 1996 Sep; 61(175):47413-23. PubMed ID: 10160337
[TBL] [Abstract][Full Text] [Related]
19. Interim recommendations for deferral of donors at increased risk for HIV-1 Group O infection; guidance document; availability--FDA. Notice.
Fed Regist; 1997 Sep; 62(184):49695. PubMed ID: 10173802
[TBL] [Abstract][Full Text] [Related]
20. [Nosocomial HIV transmission at a Danish hospital department].
Katzenstein TL; Nielsen C; Gerstoft J
Ugeskr Laeger; 1999 Nov; 161(46):6364-5. PubMed ID: 10611838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
